|Chemical and physical data|
|Molar mass||367.5 g/mol|
|3D model (Jmol)||Interactive image|
5F-CUMYL-PINACA (also known as SGT-25 and sometimes sold in e-cigarette form as C-Liquid) is an indazole-3-carboxamide based synthetic cannabinoid. 5F-CUMYL-PINACA acts as a potent agonist for the cannabinoid receptors, with approximately 4x selectivity for CB1, having an EC50 of <0.1 nM for human CB1 receptors and 0.37nM for human CB2 receptors.
- Verena Angerer; Bjoern Moosmann; Florian Franz; Volker Auwärter (2015). "5F-cumyl-PINACA in 'e-liquids' for electronic cigarettes – A new type of synthetic cannabinoid in a trendy product" (PDF). Insitute of Forensic Medicine, Forensic Toxicology, Medical Center – University of Freiburg, Germany.
- "5F-CUMYL-PINACA". Cayman Chemical. Retrieved 11 July 2015.
- Bowden; et al. (11 April 2013). "Patent WO 2014167530 - Cannabinoid compounds". New Zealand Patent application 623626. Retrieved 11 July 2015.
- "Cannabinoider föreslås bli klassade som hälsofarlig vara" [Cannabinoids suggested classified as health endangering substance] (in Swedish). Public Health Agency of Sweden. 10 November 2014. Retrieved 11 July 2015.